Literature DB >> 3147743

Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.

D Capellà1, J R Laporte, J M Castel, C Tristán, A Cos, F J Morales-Olivas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3147743      PMCID： PMC1834078          DOI： 10.1136/bmj.297.6650.722

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors:  R H Meyboom; M D Ferrari; B P Dieleman
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

2.  Useless drugs are not placebos: lessons from flunarizine and cinnarizine.

Authors:  J R Laporte; D Capella
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321

3.  [Parkinsonism possibly caused by cinnarizine].

Authors:  J F Martí Massó; N Carrera; E de la Puente
Journal:  Med Clin (Barc)       Date:  1985-11-09       Impact factor: 1.725

4.  Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors:  C Chouza; A Scaramelli; J L Caamaño; O De Medina; R Aljanati; S Romero
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321
  4 in total
  12 in total

1.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 2.  Essential tremor.

Authors:  Joaquim Jos Ferreira; Cristina Sampaio
Journal:  BMJ Clin Evid       Date:  2007-05-01

3.  A postmarketing study of flunarizine in migraine and vertigo.

Authors:  G H de Bock; J Eelhart; H W van Marwijk; T P Tromp; M P Springer
Journal:  Pharm World Sci       Date:  1997-12

4.  Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.

Authors:  Hsiu-Li Lin; Hsiu-Chen Lin; Yuan-Fu Tseng; Shih-Chang Chen; Chien-Yeh Hsu
Journal:  Eur J Clin Pharmacol       Date:  2016-12-16       Impact factor: 2.953

5.  Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.

Authors:  Renato P Munhoz; Delcio Bertucci Filho; Hélio A G Teive
Journal:  Neurol Sci       Date:  2016-11-16       Impact factor: 3.307

Review 6.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 7.  Antiparkinsonian agents. Drug interactions of clinical significance.

Authors:  R F Pfeiffer
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

8.  Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.

Authors:  Jagan R Etukala; Xue Y Zhu; Suresh V K Eyunni; Edem K Onyameh; Edward Ofori; Barbara A Bricker; Hye J Kang; Xi-Ping Huang; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2016-06-04       Impact factor: 3.641

Review 9.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

10.  Depressogenic medications and other risk factors for depression among Polish patients with epilepsy.

Authors:  Magdalena Bosak; Wojciech Turaj; Dominika Dudek; Marcin Siwek; Andrzej Szczudlik
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-30       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.